These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16672321)

  • 1. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
    Eliopoulos N; Gagnon RF; Francois M; Galipeau J
    J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
    Eliopoulos N; Lejeune L; Martineau D; Galipeau J
    Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
    Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
    Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
    Kucic T; Copland IB; Cuerquis J; Coutu DL; Chalifour LE; Gagnon RF; Galipeau J
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F488-96. PubMed ID: 18524862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic renal failure on the expression of erythropoietin message in a murine model.
    Zhang F; Laneuville P; Gagnon RF; Morin B; Brox AG
    Exp Hematol; 1996 Nov; 24(13):1469-74. PubMed ID: 8950229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
    Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
    Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.
    Hamamori Y; Samal B; Tian J; Kedes L
    J Clin Invest; 1995 Apr; 95(4):1808-13. PubMed ID: 7706487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects erythropoietin on experimental anemia in rats with chronic renal failure].
    Ling SS; Zhou Y; Sun WL; Zhu DC; Zhang HY; Tang GZ; Jin YF; Zhu JZ
    Yao Xue Xue Bao; 1992; 27(6):412-7. PubMed ID: 1442067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of electroporation-mediated erythropoietin (EPO) gene transfer into skeleton muscle on renal anemia].
    Lu X; Zhou A; Jin C
    Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):222-5. PubMed ID: 11798762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia.
    Rinsch C; Dupraz P; Schneider BL; Déglon N; Maxwell PH; Ratcliffe PJ; Aebischer P
    Kidney Int; 2002 Oct; 62(4):1395-401. PubMed ID: 12234311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
    Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J
    Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice.
    Daga A; Muraglia A; Quarto R; Cancedda R; Corte G
    Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
    Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model for an erythropoietin-deficiency anemia.
    Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K
    Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.
    Campeau PM; Rafei M; François M; Birman E; Forner KA; Galipeau J
    Mol Ther; 2009 Feb; 17(2):369-72. PubMed ID: 19088705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of erythropoietin in genetically anemic mice.
    Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
    Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering erythropoietin through genetically engineered cells.
    Bohl D; Heard JM
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S159-62. PubMed ID: 11065350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
    Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
    Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.